Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow TransplantationJeffrey A. Cohen, George E. Georges, Richard A. Nash et al.|Transplantation and Cellular Therapy|2019Cited by 106
A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801Paul A. Carpenter, Mukta Arora, Brent R. Logan et al.|Haematologica|2018Cited by 55
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHDJonathan C. Poe, Stefanie Sarantopoulos, Wei Jia et al.|Blood|2017Cited by 48
SYK inhibitor entospletinib prevents ocular and skin GVHD in miceJonathan C. Poe, Stefanie Sarantopoulos|JCI Insight|2018Cited by 48
Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHDJonathan C. Poe, Stefanie Sarantopoulos, Jiyuan Fang et al.|JCI Insight|2023Cited by 21